IKS014 in Advanced Solid Tumors That Express HER2
IKS014 in Advanced Solid Tumors That Express HER2
Recruiting · NCT05872295 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IKS014 in Advanced Solid Tumors That Express HER2 | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, skin disorder, stomach disorder | Recruiting | Phase 1 | 2026-09-28 | NCT05872295 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Iksuda Therapeutics Ltd. | 3 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Alfred Health | Melbourne | Australia | 32 |
| Auckland City Hospital | Auckland | New Zealand | 23 |
| Concord Repatriation General Hospital Medical Oncology Clinical Trials Unit | Concord | Australia | 1 |
| Dana Farber Cancer Institute | Boston | United States | 300 |
| Hoag Memorial Hospital Presbyterian | Newport Beach | United States | 66 |
| Linear Clinical Research | Nedlands | Australia | 23 |
| Macquarie University | Sydney | Australia | 10 |
| National Cancer Centre Singapore | Singapore | Singapore | 8 |
| Peninsula & South Eastern Haematology and Oncology Group (PSEHOG) | Frankston | Australia | 1 |
| START Dallas - Fort Worth | Fort Worth | United States | 1 |
| Tan Tock Seng Hospital | Singapore | Singapore | 22 |
| Tennessee Oncology | Nashville | United States | 77 |
| Westmead Hospital | Westmead | Australia | 128 |